A Practice Brief examining the use of creatine monohydrate for the treatment of muscle weakness in Duchenne Muscular Dystrophy (DMD) has just been released.
Professor Monique Ryan and her team at the Royal Children's Hospital and Centre of Research Excellence in Neuromuscular Disorders have developed the Practice Brief for paediatricians, paediatric neurologists and other medical & allied health professionals involved in the care of those with DMD.
What does the practice brief provide?
- A summary of the evidence on dietary supplementation in DMD with creatine monohydrate
- Guidance on creatine monohydrate dosing in DMD
- Key sources of information and support for those with DMD and their treating health professionals